6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,298 / 薬物数 : 2,202 - (DrugBank : 350) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 202

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03652870 (ClinicalTrials.gov)	November 1, 2019	8/8/2018	Antidepressants Trial in Parkinson's Disease	A Randomised Placebo-Controlled Trial of Escitalopramand Nortriptyline With Standard Psychological C ...	Depression;Parkinson Disease	Drug: Nortriptyline;Drug: Escitalopram;Drug: Placebo	University College, London	London North West Healthcare NHS Trust;King's College London;University Hospital Plymouth NHS Trust; ...	Not yet recruiting	18 Years	85 Years	All	408	Phase 3	NULL
2	EUCTR2018-002942-35-GB (EUCTR)	31/10/2019	05/09/2019	A Randomised Controlled Trial of Escitalopramand Nortriptyline compared with placebo, and standard p ...	A Randomised Controlled Trial of Escitalopramand Nortriptyline compared with placebo and standard ps ...	Depression in Parkinson's disease MedDRA version: 20.0;Level: PT;Classification code 10012378;Term: ...	Product Name: Escitalopram INN or Proposed INN: Escitalopram oxalate Trade Name: Nortriptyline Product N ...	University College London Comprehensive Clinical Trials Unit	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	408	Phase 3	United Kingdom
3	EUCTR2007-004009-93-IT (EUCTR)	20/05/2008	14/07/2008	Prevalence of depression,anxiety and impulse control disorder (ICD) in patients with Parkinson's dis ...	Prevalence of depression,anxiety and impulse control disorder (ICD) in patients with Parkinson's dis ...	Depression, anxiety and ICD MedDRA version: 14.1;Level: SOC;Classification code 10037175;Term: Psych ...	Trade Name: CIPRALEX INN or Proposed INN: Escitalopram Trade Name: CIPRALEX INN or Proposed INN: Escita ...	LUNDBECK ITALIA	NULL	Not Recruiting			Female: yes Male: yes			Italy
4	NCT00070941 (ClinicalTrials.gov)	July 2003	9/10/2003	SAM-e for the Treatment of Depression in Patients With Parkinson's Disease	SAM-e Treatment of Depression in Parkinson's Disease.	Parkinson's Disease;Depression	Drug: SAM -e;Drug: oral escitalopram;Drug: placebo	New York University School of Medicine	National Center for Complementary and Integrative Health (NCCIH);Office of Dietary Supplements (ODS) ...	Completed	30 Years	80 Years	All	29	Phase 2/Phase 3	United States

First Previous1Next Last